MCP
GH icon

Meridiem Capital Partners’s Guardant Health GH Stock Holding History

Meridiem Capital Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-36,681
Closed -$2.29M – 86
2025
Q3 		$2.29M Sell
36,681
-14,101
-28% -$767K 0.15% 64
2025
Q2 		$2.64M Buy
+50,782
New +$2.27M 0.19% 65

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Meridiem Capital Partners's GH Position: Q4 2025 in Review

Meridiem Capital Partners sold out of Guardant Health (GH) in Q4 2025, closing a stake of 36,681 shares — an estimated $2.29M sold.

Meridiem Capital Partners first reported a position in GH in Q2 2025 and held it in 2 quarters. The position peaked at $2.64M in Q2 2025. 495 funds tracked by Wall St. Rank hold GH as of Q4 2025.

  • Meridiem Capital Partners reported no remaining Guardant Health position as of Q4 2025 after selling out during the quarter.
  • Meridiem Capital Partners sold 36,681 Guardant Health shares in Q4 2025, an estimated $2.29M.
  • Meridiem Capital Partners first reported a position in Guardant Health in Q2 2025 and held it in 2 quarters.
  • Meridiem Capital Partners's Guardant Health position peaked at $2.64M in Q2 2025.
  • 495 funds tracked by Wall St. Rank held Guardant Health as of Q4 2025.

Based on Meridiem Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.